ロード中...
Response to PD1 inhibition in conventional chondrosarcoma
BACKGROUND: Chondrosarcoma is one of the most common malignant bone tumors in adults. Conventional chondrosarcoma represents around 85% of all chondrosarcomas and is notoriously difficult to treat with chemotherapy. CASE PRESENTATION: We describe a 67-year-old man with metastatic conventional chondr...
保存先:
| 出版年: | J Immunother Cancer |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6156853/ https://ncbi.nlm.nih.gov/pubmed/30253794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0413-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|